Free Trial

Peak6 LLC Buys New Position in Chemed Co. (NYSE:CHE)

Chemed logo with Medical background

PEAK6 LLC purchased a new stake in shares of Chemed Co. (NYSE:CHE - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 777 shares of the company's stock, valued at approximately $412,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. CIBC Asset Management Inc boosted its holdings in shares of Chemed by 5.1% during the 4th quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock valued at $242,000 after buying an additional 22 shares in the last quarter. CBIZ Investment Advisory Services LLC lifted its holdings in shares of Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after purchasing an additional 22 shares during the last quarter. CIBC Private Wealth Group LLC boosted its position in shares of Chemed by 13.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock worth $98,000 after purchasing an additional 22 shares in the last quarter. Independent Advisor Alliance grew its stake in shares of Chemed by 1.1% in the 4th quarter. Independent Advisor Alliance now owns 2,279 shares of the company's stock worth $1,207,000 after buying an additional 25 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in Chemed by 7.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company's stock valued at $264,000 after buying an additional 33 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Stock Performance

Shares of NYSE:CHE traded up $9.79 during midday trading on Friday, reaching $556.57. 80,564 shares of the company's stock traded hands, compared to its average volume of 99,390. Chemed Co. has a one year low of $512.12 and a one year high of $623.61. The company has a market cap of $8.13 billion, a price-to-earnings ratio of 28.12, a P/E/G ratio of 2.15 and a beta of 0.49. The stock has a 50 day moving average of $587.53 and a 200 day moving average of $567.32.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. Chemed's dividend payout ratio is presently 10.05%.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the business's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the sale, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.32% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have commented on CHE shares. Royal Bank of Canada boosted their target price on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a report on Friday, March 14th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.

Get Our Latest Research Report on CHE

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines